2022 - How Early Detection & Diagnostic Products Will Shape the Future of Healthcare

The clinical trial pipeline of early detection and diagnostic products is rapidly expanding. Since healthcare can often be better characterized as “sick care,” this expansion holds great promise for intersecting with patients earlier in their disease progression to improve outcomes. However, the historic utilization of currently available screening tools indicates significant barriers to the greater adoption of new diagnostic methods and products.
What impacts the diagnostic process within healthcare? How can the lessons learned from these barriers inform clinical trial design to reduce the gap from discovery to utilization and payor coverage?
In this webinar, the featured speakers will explore the barriers between healthcare and new early detection and diagnostic methods and how the strategies used to overcome such challenges can be applied to clinical research, ultimately translating to a more patient-centered trial experience and faster adoption of life-improving and lifesaving tools.
Register for this Elligo Elite Learning Series webinar for expert insights and an engaging discussion on how early detection and diagnostic products will shape the future of healthcare.